Expression profiles of circular RNA in human placental villus and decidua and prediction of drugs for recurrent spontaneous abortion-Reference-Cited by-同舟云学术

Expression profiles of circular RNA in human placental villus and decidua and prediction of drugs for recurrent spontaneous abortion

Published:2022-05-29 Issue:1 Volume:88 Page:
ISSN:1046-7408
Container-title:American Journal of Reproductive Immunology
language:en
Short-container-title:American J Rep Immunol

Author:

Liu Junwei¹^ORCID,Gu Yan²,Zhu Weiqiang¹,Zhang Zhaofeng¹,Xin Yawei²,Shen Yupei¹,He Lin³,Du Jing¹^ORCID

Affiliation:

1. NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), School of Pharmacy Fudan University Shanghai China

2. The Second Hospital of Tianjin Medical University Tianjin China

3. Bio‐X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Obstetrics and Gynecology,Reproductive Medicine,Immunology,Immunology and Allergy,Obstetrics and Gynecology,Immunology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aji.13578

Reference60 articles.

1. Recurrent miscarriage

2. Evaluation and treatment of recurrent pregnancy loss: a committee opinion

3. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development

4. Recurrent pregnancy loss: A summary of international evidence-based guidelines and practice

5. DNA methylation defects in spermatozoa of male partners from couples experiencing recurrent pregnancy loss;Khambata K;Hum Reprod,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis;Heliyon;2024-09

2. SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis;2023-10-28